ARAV

Aravive (ARAV)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARAV
DataOraFonteTitoloSimboloCompagnia
08/02/202413:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ARAVAravive Inc
02/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ARAVAravive Inc
29/01/202422:17Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ARAVAravive Inc
29/01/202422:10Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ARAVAravive Inc
29/01/202422:06Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ARAVAravive Inc
17/01/202422:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARAVAravive Inc
17/01/202422:09GlobeNewswire Inc.Aravive, Inc. to Delist from The Nasdaq Stock MarketNASDAQ:ARAVAravive Inc
09/11/202322:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARAVAravive Inc
22/09/202323:04Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:ARAVAravive Inc
05/09/202322:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARAVAravive Inc
25/08/202313:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ARAVAravive Inc
24/08/202323:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ARAVAravive Inc
14/08/202322:06Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ARAVAravive Inc
20/06/202322:12Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARAVAravive Inc
05/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARAVAravive Inc
10/05/202322:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARAVAravive Inc
01/05/202318:50Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ARAVAravive Inc
19/04/202322:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARAVAravive Inc
11/04/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARAVAravive Inc
11/04/202322:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARAVAravive Inc
15/03/202312:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARAVAravive Inc
14/02/202322:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARAVAravive Inc
28/12/202222:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARAVAravive Inc
29/11/202214:04Dow Jones NewsAravive Shares Rise Premarket on FDA Fast-Track Designation for BatiraxceptNASDAQ:ARAVAravive Inc
17/11/202222:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARAVAravive Inc
10/11/202216:15TipRanksH.C. Wainwright Sticks to Their Buy Rating for Aravive (ARAV)NASDAQ:ARAVAravive Inc
28/10/202222:12Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARAVAravive Inc
10/10/202222:05GlobeNewswire Inc.Aravive Receives Third Development Milestone from 3D MedicinesNASDAQ:ARAVAravive Inc
26/09/202214:00GlobeNewswire Inc.Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc ConferenceNASDAQ:ARAVAravive Inc
06/09/202222:05GlobeNewswire Inc.Aravive to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:ARAVAravive Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARAV
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network